By Yolanda Smith, BPharm
Osteosarcoma is a malignant neoplasm of the bone and is the most common histological form of primary bone cancer. It is most prevalent in children and young adults, as it is associated with the formation and growth of bone. It is unsurprising, then, that it is the eighth most common type of childhood cancer.
X-ray imaging reveals that the tumor is solid, hard and irregular, with an appearance similar to a fir-tree or as if it has been moth-eaten. This distinctive look is likely due to the calcified bone radiating at right angles in the tumor spicules, which is known as Codman’s triangle.
The tissue surrounding the osteosarcoma is usually infiltrated. On a microscopic level, the tumor cells are very pleomorphic (anaplastic) and some are large atypical mitoses. The cells are known to produce osteoid, which are irregular trabeculae that may or may not have central calcification.
The cells are found within the osteoid matrix and can be classified according to their specific features, such as their resemblance to bone cells, cartilage cells or fibroblast cells. They may also be multinucleated and exhibit osteoclast-like characteristics.
Osteosarcoma most commonly occurs at growth sites of the bone because the osteoblasts proliferate in this region and may acquire mutations and lead to the condition. The localization of the tumor to the end of long bones such as the metaphysis is widespread.
The most frequently affected areas are the proximal end of the tibia or humerus, or the distal end of the femur. In fact, bones located around the knee region account for up to 60% of osteosarcoma cases – 42% in the femur and 19% in the tibia. Other bones that are often involved are those around the hip for approximately 15% of cases, 10% around the shoulder and 8% in the jaw.
Osteosarcoma originates from mesenchymal cells that are primitive transformed. This leads the differentiation of osteoblastic cells and the production of malignant osteoid cells.
Some genes have been associated with the involvement of osteosarcoma genesis, such as the retinoblastic gene and the TP53 gene.
The primary cause of osteosarcoma remains to be seen although it is likely that more than one factor may increase risk of being affected. There is currently research being done that investigates the ability of cancer stem cells to cause the tumors.
Radiotherapy used to treat previous medical conditions may be a cause, however this is a rare circumstance, as most children and young adults are not subjected to radiotherapy.
It may also have a hereditary factor. In particular, families where chromosome 13q14 is deleted and the retinoblastoma gene inactivated face a higher risk of the condition. Additionally, Li-Fraumeni syndrome involves a mutation of the germline TP53 and is linked to osteosarcoma development.
Some other health conditions have been linked to the disease, such as bone dysplasias, Paget’s disease, fibrous dysplasia, enchondromatosis, mulitpe exostosis and Rothmund-Thompson syndrome.
There has been some speculation as to the role of fluoride in drinking water on the risk of developing osteosarcoma. This stemmed from a study in the 1990 that presented a weak association between fluoride and cancer in mice. However, this has not been confirmed with sufficient evidence to claim that fluoridation of water may cause the disease.
Last Updated: Mar 30, 2015